Prognostic Value of Pre- and Post-Treatment PET-CT Metrics After Definitive Chemoradiation for Anal Canal Cancer
Year: 2026
Type: article
Study design: Observational Study
Abstract: PURPOSE: Although post-treatment FDG-PET/CT is frequently obtained following definitive chemoradiation (CRT) for locally advanced anal canal cancer (LAACC), its prognostic utility remains uncertain. We hypothesized that quantitative PET/CT metrics would be associated with overall survival (OS) and that pre-treatment metabolic parameters would provide greater prognostic information than post-treatment metabolic response. METHODS: We conducted a retrospective cohort study of patients with LAACC who underwent definitive CRT and both pre-treatment and post-treatment fluorodeoxyglucose (FDG) PET/CT. Quantitative PET metrics were extracted, including mean SUL, total lesion glycolysis (TLG), metabolic tumor volume (MTV), maximum SUL, and peak SUL. OS was estimated using the Kaplan-Meier method. Associations between PET-derived variables and OS were evaluated using univariable Cox proportional hazards regression, with optimal cutoffs identified using maximally selected rank statistics (MaxStat). RESULTS: Forty-five patients were included (median age 57.7 years), with post-treatment PET/CT performed at a median of 4.4 months following CRT. Lean body mass (HR 3.10, 95% CI 1.01-9.50; p = 0.049) and pre-treatment primary tumor mean SUL (HR 4.93, 95% CI 1.40-17.37; p = 0.013), size (HR 4.01, 95% CI 1.22-13.17; p = 0.022), TLG (HR 3.68, 95% CI 1.11-12.14; p = 0.033), and peak SUL (HR 3.31, 95% CI 1.02-10.72; p = 0.046) were associated with OS in exploratory univariable analyses. Post-treatment, higher weight (HR 4.94, 95% CI 1.06-22.96; p=0.041; cutoff 60.42 kg; N=45) and lean body mass (HR 4.82, 95% CI 1.06-21.90; p=0.042; cutoff 44.50 kg; N=44) were associated with worse OS. No post-treatment PET-derived metabolic parameters met the nominal threshold for statistical significance. Among patients with higher baseline metabolic activity, greater reduction in mean SUL following CRT demonstrated a nonsignificant trend toward improved OS. CONCLUSION: Pre-treatment FDG-PET/CT metabolic parameters demonstrated stronger associations with OS than post-treatment metabolic parameters in this exploratory cohort. Baseline tumor metabolic activity may provide useful prognostic information in patients with LAACC, warranting validation in larger prospective studies.
Institutions: University of Miami, Sylvester Comprehensive Cancer Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: anal cancer, locally advanced anal cancer, definitive chemoradiotherapy, FDG PET/CT, prognostic factors, overall survival, standardized uptake value, total lesion glycolysis, metabolic tumor volume, lean body mass, weight, tumor size, treatment response assessment, prognostic cutoff values
Open Access status: hybrid
Estimated APC paid: $4,190
OpenAlex ID: W7236659520
